Home › NDC Lookup › RxCUI directory › RxCUI 351875

72 HR scopolamine 0.0139 MG/HR Transdermal System [Transderm Scop] — RxCUI 351875

RxNorm drug concept · Semantic branded drug
RxCUI 351875 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI351875
Official name72 HR scopolamine 0.0139 MG/HR Transdermal System [Transderm Scop]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asTransderm Scop 1.3 MG 3 Day Transdermal System; TRANSDERM SCOP 1 MG 3 Day Transdermal System; 72 HR Transderm Scop 0.0139 MG/HR Transdermal System; Transderm Scop 0.0139 MG/HR 72 HR Transdermal Patch; Transderm Scop 0.33 MG/Day 72 HR Transdermal Patch
FDA products mapped1
Package NDCs mapped4
Reported Medicaid activity (SDUD)32 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Scopolamine Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Apply it to the hairless skin directly behind one ear — that flat area just behind the earlobe. Either side works fine. The key is that the skin is clean, dry, and hair-free so the...
  • Where exactly do I put the patch, and does it matter which side?
  • Put it on at least 4 hours before you need it to be working — so if you're boarding a cruise ship in the morning, apply it the night before. The patch takes several hours to build...
  • How soon before a trip should I put the patch on?
📖 Read our full Scopolamine Transdermal Patch guide →

🕸️ Concept Web — How 72 HR scopolamine 0.0139 MG/HR Transdermal Syste... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 72 HR scopolamine 0.0139 MG/HR Transdermal System [Transderm Scop] RxCUI 351875

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Scopolamine 9601
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Transderm Scop 220372
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Scopolamine Transdermal System 1806049
    • Scopolamine Topical Product 1157630
    • Scopolamine Transdermal Product 1295698
    • Scopolamine Transdermal System [Transderm Scop] 1806063
    • Transderm Scop Topical Product 1179184
    • Transderm Scop Transdermal Product 1296025
    • Transdermal System 316987
    • Topical Product 1151122
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Scopolamine 0.0139 MG/HR [Transderm Scop] SBDC · 575640
  • Scopolamine Transdermal System [Transderm Scop] SBDF · 1806063
  • Transderm Scop Topical Product SBDG · 1179184
  • Transderm Scop Transdermal Product SBDG · 1296025
  • Transderm Scop BN · 220372

📦 FDA Products & Package NDCs

1 product · 4 package NDCs
4 package NDCs map to RxCUI 351875 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
10019-0008-01 1 PATCH in 1 POUCH (10019-008-01) / 3 d in 1 PATCH Transderm Scop Baxter Healthcare Corporation 2026-06-10
10019-0008-04 4 POUCH in 1 BOX (10019-008-04) / 1 PATCH in 1 POUCH / 3 d... Transderm Scop Baxter Healthcare Corporation 2025-06-10
10019-0008-10 10 POUCH in 1 BOX (10019-008-10) / 1 PATCH in 1 POUCH / 3 d... Transderm Scop Baxter Healthcare Corporation 2025-06-10
10019-0008-24 24 POUCH in 1 BOX (10019-008-24) / 1 PATCH in 1 POUCH / 3 d... Transderm Scop Baxter Healthcare Corporation 2025-06-10
Observed labelers: Baxter Healthcare Corporation (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$11.2366
Range $11.2366–$11.2366 · middle 50% $11.2366–$11.2366 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.